Claire E Holland1, Seni Kouanda2, Marcel Lougué3, Vincent Palokinam Pitche4, Sheree Schwartz1, Simplice Anato5, Henri Gautier Ouedraogo6, Jules Tchalla7, Clarence S Yah1, Laurent Kapesa8, Sosthenes Ketende1, Chris Beyrer1, Stefan Baral1. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 2. Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso, West Africa; Institut Africain de Santé Publique, Ouagadougou, Burkina Faso, West Africa. 3. Programme d'Appui au Monde Associatif et Communautaire, Ouagadougou, Burkina Faso, West Africa. 4. National AIDS Council, Lomé, Togo, West Africa; University of Lomé, Lomé, Togo, West Africa. 5. Arc-en-Ciel, Lomé, Togo, West Africa. 6. Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso, West Africa. 7. Espoir Vie-Togo, Lomé, Togo, West Africa. 8. USAID West Africa, Accra, Ghana, West Africa.
Abstract
OBJECTIVES: The objective of our study was to measure progress toward the UNAIDS 90-90-90 HIV care targets among key populations in urban areas of 2 countries in West Africa: Burkina Faso and Togo. METHODS: We recruited female sex workers (FSWs) and men who have sex with men (MSM) through respondent-driven sampling. From January to July 2013, 2738 participants were enrolled, tested for HIV, and completed interviewer-administered surveys. We used population-size estimation methods to calculate the number of people who were engaged in the HIV continuum of care. RESULTS: HIV prevalence ranged from 0.6% (2 of 329) of MSM in Kara, Togo, to 32.9% (115 of 350) of FSWs in Bobo Dioulasso, Burkina Faso. Of those confirmed to be HIV infected, a range of 0.0% (0 of 2) of MSM in Kara to 55.7% (64 of 115) of FSWs in Bobo Dioulasso were using ART. Based on population estimates, the percentage gap between HIV-infected people who should be using ART (per the 90-90-90 targets) and those who reported using ART ranged from 31.5% among FSWs in Bobo Dioulasso to 100.0% among MSM in Kara. CONCLUSIONS: HIV service coverage among MSM and FSWs in Burkina Faso and Togo was low in 2013. Interventions for improving engagement of these at-risk populations in the HIV continuum of care should include frequent, routine HIV testing and linkage to evidence-based HIV treatment services. Population-size estimates can be used to inform governments, policy makers, and funding agencies about where elements of HIV service coverage are most needed.
OBJECTIVES: The objective of our study was to measure progress toward the UNAIDS 90-90-90 HIV care targets among key populations in urban areas of 2 countries in West Africa: Burkina Faso and Togo. METHODS: We recruited female sex workers (FSWs) and men who have sex with men (MSM) through respondent-driven sampling. From January to July 2013, 2738 participants were enrolled, tested for HIV, and completed interviewer-administered surveys. We used population-size estimation methods to calculate the number of people who were engaged in the HIV continuum of care. RESULTS: HIV prevalence ranged from 0.6% (2 of 329) of MSM in Kara, Togo, to 32.9% (115 of 350) of FSWs in Bobo Dioulasso, Burkina Faso. Of those confirmed to be HIV infected, a range of 0.0% (0 of 2) of MSM in Kara to 55.7% (64 of 115) of FSWs in Bobo Dioulasso were using ART. Based on population estimates, the percentage gap between HIV-infected people who should be using ART (per the 90-90-90 targets) and those who reported using ART ranged from 31.5% among FSWs in Bobo Dioulasso to 100.0% among MSM in Kara. CONCLUSIONS: HIV service coverage among MSM and FSWs in Burkina Faso and Togo was low in 2013. Interventions for improving engagement of these at-risk populations in the HIV continuum of care should include frequent, routine HIV testing and linkage to evidence-based HIV treatment services. Population-size estimates can be used to inform governments, policy makers, and funding agencies about where elements of HIV service coverage are most needed.
Authors: Stefan Baral; Chris Beyrer; Kathryn Muessig; Tonia Poteat; Andrea L Wirtz; Michele R Decker; Susan G Sherman; Deanna Kerrigan Journal: Lancet Infect Dis Date: 2012-03-15 Impact factor: 25.071
Authors: Katharina Kranzer; Darshini Govindasamy; Nathan Ford; Victoria Johnston; Stephen D Lawn Journal: J Int AIDS Soc Date: 2012-11-19 Impact factor: 5.396
Authors: Sean T Allen; Allison O'Rourke; Rebecca Hamilton White; Kristin E Schneider; Michael Kilkenny; Susan G Sherman Journal: Am J Public Health Date: 2019-01-24 Impact factor: 9.308
Authors: James Stannah; Elizabeth Dale; Jocelyn Elmes; Roisin Staunton; Chris Beyrer; Kate M Mitchell; Marie-Claude Boily Journal: Lancet HIV Date: 2019-10-07 Impact factor: 12.767
Authors: Jennifer L Glick; Rienna G Russo; Aimee Kao-Hsuan Huang; Belinda Jivapong; Vijayasundaram Ramasamy; Lori M Rosman; Danielle L Pelaez; Susan G Sherman Journal: Glob Public Health Date: 2020-12-10
Authors: Xiaoyue Maggie Niu; Amrita Rao; David Chen; Ben Sheng; Sharon Weir; Eric Umar; Gift Trapence; Vincent Jumbe; Dunker Kamba; Katherine Rucinski; Nikita Viswasam; Stefan Baral; Le Bao Journal: Ann Epidemiol Date: 2020-12-16 Impact factor: 3.797
Authors: Sharon Stucker Weir; Stefan D Baral; Jessie K Edwards; Sabrina Zadrozny; James Hargreaves; Jinkou Zhao; Keith Sabin Journal: JMIR Public Health Surveill Date: 2018-05-22
Authors: Elizabeth Fearon; Sungai T Chabata; Jennifer A Thompson; Frances M Cowan; James R Hargreaves Journal: JMIR Public Health Surveill Date: 2017-09-14
Authors: Nikita Viswasam; Carrie E Lyons; Jack MacAllister; Greg Millett; Jennifer Sherwood; Amrita Rao; Stefan D Baral Journal: PLoS One Date: 2020-02-26 Impact factor: 3.240
Authors: P H Septime Hessou; Yolaine Glele-Ahanhanzo; Rheda Adekpedjou; Carin Ahouada; R Christian Johnson; Michel Boko; Hervé Tchala Vignon Zomahoun; Michel Alary Journal: BMC Public Health Date: 2019-12-04 Impact factor: 3.295
Authors: Sean T Allen; Kristin E Schneider; Alyona Mazhnaya; Rebecca Hamilton White; Allison O'Rourke; Alex H Kral; Ricky N Bluthenthal; Michael E Kilkenny; Susan G Sherman Journal: AIDS Behav Date: 2021-06-02